As directed by President Trump’s Executive Order on Improving Price and Quality Transparency in American Healthcare, today the Department of Health and Human Services is announcing that the Centers for Medicare & Medicaid Services (CMS) is issuing two rules that take historic steps to increase price transparency to empower patients and increase competition among all hospitals, group health plans and health insurance issuers in the individual and group markets.
Coverage Leadership Legislation Quality
The CY 2020 Physician Fee Schedule Final Rule (CMS-1715-F) establishes Medicare Coverage for Opioid Use Disorder Treatment Services Furnished by Opioid Treatment Programs.
The Centers for Medicare & Medicare Services (CMS) announced today the top 25 participants selected to advance to Stage 1 of the CMS Artificial Intelligence (AI) Health Outcomes Challenge.
Today, the Centers for Medicare & Medicaid Services (CMS) issued a final rule with comment period [CMS-1711-FC] that finalizes routine updates to the home health payment rates for calendar year (CY) 2020, in accordance with existing statutory and regulatory requirements.
Today, the Trump Administration and the Centers for Medicare & Medicaid Services (CMS) finalized changes to the Medicare rules for Durable Medical Equipment Prosthetics, Orthotics, and Supplies (DMEPOS), the End-Stage Renal Disease (ESRD) Prospective Payment System (PPS), and the ESRD Quality Incentive Program (QIP).
On October 31, 2019, the Centers for Medicare & Medicaid Services (CMS) issued a final rule that updates payment policies and rates under the End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) for renal dialysis services furnished to beneficiaries on or after January 1, 2020.
Today, consistent with the direction of President Trump’s Executive Order on Protecting and Improving Medicare for Our Nation’s Seniors, the Centers for Medicare & Medicaid Services (CMS) finalized significant changes to the Home Health Prospective Payment System (HH PPS), including a new home infusion therapy benefit that builds on the historic steps we have already taken to strengthen and protect the Medicare program by increasing choices and empowering patients.